We reach more than 65,000 registered users in Dec!!

Drugs with multiple targets show promise against myotonic dystrophy type 1

Efforts to treat myotonic dystrophy type 1, the most common form of muscular dystrophy, are in their infancy. In a new study, researchers report they have added new capabilities to an experimental drug agent that previously defeated only one of DM1's many modes of action. Their retooled compounds interrupt the disease's pathology in three ways.

Leave a comment

Search Similar Posts

    No tags found for this post